Cardiovascular outcomes and LDL-cholesterol levels in EMPA-REG OUTCOME(®)

OBJECTIVE: It is well established that higher low-density lipoprotein (LDL)-cholesterol levels are associated with increased cardiovascular risk. We analyzed whether effects of empagliflozin on cardiovascular outcomes varied by different LDL-cholesterol levels at baseline in EMPA-REG OUTCOME. METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales: Langslet, Gisle, Zinman, Bernard, Wanner, Christoph, Hantel, Stefan, Espadero, Rosa-Maria, Fitchett, David, Johansen, Odd Erik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7919220/
https://www.ncbi.nlm.nih.gov/pubmed/33307785
http://dx.doi.org/10.1177/1479164120975256

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7919220/
https://www.ncbi.nlm.nih.gov/pubmed/33307785
http://dx.doi.org/10.1177/1479164120975256

Ejemplares similares